Renasant (RNST)
(Delayed Data from NYSE)
$29.85 USD
-0.06 (-0.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $29.86 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Income Statements
Fiscal Year end for Renasant Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 910 | 691 | 696 | 734 | 696 |
Cost Of Goods | 232 | 35 | 29 | 54 | 82 |
Gross Profit | 678 | 656 | 667 | 680 | 614 |
Selling & Adminstrative & Depr. & Amort Expenses | 455 | 417 | 428 | 551 | 381 |
Income After Depreciation & Amortization | 223 | 239 | 239 | 128 | 233 |
Non-Operating Income | 0 | 1 | 0 | -7 | 0 |
Interest Expense | 46 | 25 | 16 | 17 | 17 |
Pretax Income | 177 | 211 | 223 | 103 | 216 |
Income Taxes | 33 | 45 | 47 | 20 | 48 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 145 | 166 | 176 | 84 | 168 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 145 | 166 | 176 | 84 | 168 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 258 | 282 | 286 | 163 | 241 |
Depreciation & Amortization (Cash Flow) | 35 | 43 | 47 | 35 | 8 |
Income After Depreciation & Amortization | 223 | 239 | 239 | 128 | 233 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.45 | 56.21 | 56.43 | 56.47 | 58.23 |
Diluted EPS Before Non-Recurring Items | 3.15 | 3.00 | 2.98 | 1.93 | 2.91 |
Diluted Net EPS (GAAP) | 2.56 | 2.95 | 3.12 | 1.48 | 2.88 |
Fiscal Year end for Renasant Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 230.79 | 243.88 | 214.39 | 221.34 |
Cost Of Goods | NA | 77.17 | 70.91 | 51.39 | 32.87 |
Gross Profit | NA | 153.62 | 172.97 | 163.00 | 188.47 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 114.39 | 112.98 | 112.17 | 115.67 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 39.23 | 59.99 | 50.83 | 72.80 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 7.31 | 7.39 | 15.56 | 15.40 |
Pretax Income | NA | 31.91 | 52.60 | 35.28 | 57.40 |
Income Taxes | NA | 3.79 | 10.77 | 6.63 | 11.32 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 28.12 | 41.83 | 28.64 | 46.08 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 28.12 | 41.83 | 28.64 | 46.08 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 56.61 | 56.52 | 56.40 | 56.27 |
Diluted EPS Before Non-Recurring Items | NA | 0.76 | 0.75 | 0.83 | 0.82 |
Diluted Net EPS (GAAP) | NA | 0.49 | 0.74 | 0.51 | 0.82 |